A systematic review of the use of economic evaluation in local decision-making.
暂无分享,去创建一个
[1] C. Ham,et al. Health Policy in Britain , 1982 .
[2] J. Schulenburg. The Influence of Economic Evaluation Studies on Health Care Decision-Making: A European Survey , 2000 .
[3] Economic evaluation in health care: the point of view of informed physicians. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[4] Douglas K. Martin,et al. Priority setting for new technologies in medicine: qualitative case study , 2000, BMJ : British Medical Journal.
[5] Maarten J. IJzerman,et al. PRE-ASSESSMENT TO ASSESS THE MATCH BETWEEN COST-EFFECTIVENESS RESULTS AND DECISION MAKERS' INFORMATION NEEDS , 2003, International Journal of Technology Assessment in Health Care.
[6] D. Hailey. Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies. , 1997, Social science & medicine.
[7] C. Mitton,et al. Resource Allocation in Health Care: Health Economics and Beyond , 2003, Health Care Analysis.
[8] N. Powe,et al. The review process used by U.S. health care plans to evaluate new medical technology for coverage , 1996, Journal of General Internal Medicine.
[9] D. McDaid,et al. Evaluating health care interventions in the European Union. , 2003, Health policy.
[10] C. Donaldson,et al. Economics, Public Health and Health Care Purchasing: The Tayside Experience of Programme Budgeting and Marginal Analysis , 1996, Journal of health services research & policy.
[11] J. Graf von der Schulenburg,et al. The influence of economic evaluation studies on decision making. A European survey. The EUROMET group. , 2000, Health policy.
[12] P. Trueman,et al. Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'? , 1999, Health policy.
[13] Jeffrey K Aronson,et al. The road to health care , 2004, BMJ : British Medical Journal.
[14] J. Coast. Is economic evaluation in touch with society's health values? , 2004, BMJ : British Medical Journal.
[15] Sheila Leatherman,et al. The business case for quality: case studies and an analysis. , 2003, Health affairs.
[16] S. Sullivan,et al. Economic evaluation in the US: what is the missing link? , 2006, PharmacoEconomics.
[17] A. Ludbrook. Economic appraisal in the National Health Service: a survey. , 1986, Health policy.
[18] M. Drummond,et al. Economic evaluation under managed competition: evidence from the U.K. , 1997, Social science & medicine.
[19] J. Grand. THE LABOUR GOVERNMENT AND THE NATIONAL HEALTH SERVICE , 2002 .
[20] R. Rosen. Applying Research to Health Care Policy and Practice: Medical and Managerial Views on Effectiveness and the Role of Research , 2000, Journal of health services research & policy.
[21] M. Drummond,et al. Economic evaluations of drug therapy: attitudes of primary care prescribing advisers in Great Britain. , 1997, Health policy.
[22] S. Twaddle,et al. Programme budgeting and marginal analysis: application within programmes to assist purchasing in Greater Glasgow Health Board. , 1995, Health policy.
[23] Douglas K. Martin,et al. Priority setting in a hospital drug formulary: a qualitative case study and evaluation. , 2003, Health policy.
[24] K. Whetten-Goldstein,et al. Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis. , 1997, Social science & medicine.
[25] C. Mitton,et al. Cost effectiveness analysis in health care: contraindications , 2002, BMJ : British Medical Journal.
[26] Managed care pharmacy, socioeconomic assessments and drug adoption decisions. , 1997, Social science & medicine.
[27] J. Eisenberg,et al. Are we ready to use cost-effectiveness analysis in health care decision-making? A health services research challenge for clinicians, patients, health care systems, and public policy. , 1998, Medical care.
[28] Rationality and reality: Attitudes of health economists working at local level in the UK National Health Service , 2001 .
[29] M. Drummond,et al. Using economic evidence to support decision making: a case study of assertive community treatment within the UK National Service Framework for Mental Health. , 2002, Applied health economics and health policy.
[30] Economic evaluation of medical technologies in Sweden. , 1997, Social science & medicine.
[31] J. Coast,et al. Citizens, their agents and health care rationing: an exploratory study using qualitative methods. , 2001, Health economics.
[32] J. Baron,et al. The influence of cost-effectiveness information on physicians' cancer screening recommendations. , 2003, Social science & medicine.
[33] Martina Garau,et al. Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study , 2004, BMJ : British Medical Journal.
[34] A. Anell,et al. Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees. , 2000, PharmacoEconomics (Auckland).
[35] Trevor A Sheldon,et al. What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews , 2004, BMJ : British Medical Journal.
[36] J. Ross,et al. The use of economic evaluation in health care: Australian decision makers' perceptions. , 1995, Health policy.
[37] M. Drummond,et al. Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[38] S. Duckett. Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme , 2004, Health care financing review.
[39] Douglas K. Martin,et al. Priority-setting decisions for new cancer drugs: a qualitative case study , 2001, The Lancet.
[40] P. Neumann. Why don't Americans use cost-effectiveness analysis? , 2004, The American journal of managed care.
[41] S. Peacock. An evaluation of program budgeting and marginal analysis applied in South Australian hospitals , 1998 .
[42] S. Bryan,et al. Cost-effectiveness analysis and formulary decision making in England: findings from research. , 2007, Social science & medicine.
[43] E. Adang,et al. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions. , 2005, Health policy.
[44] M. Drummond,et al. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[45] Criteria to Request Pharmacoeconomic Data and Data Sources for Hospital Formulary Decisions , 2001 .
[46] Ruth E. Brown,et al. The Use of Technology Assessment by Hospitals, Health Maintenance Organizations, and Third-Party Payers in the United States , 1995, International Journal of Technology Assessment in Health Care.
[47] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[48] N. Barber,et al. What constitutes evidence in hospital new drug decision making? , 2004, Social science & medicine.
[49] J. Collet,et al. “Cost-effectiveness” Estimates Result in Flawed Decisionmaking in Listing Drugs for Reimbursement , 2002, Canadian journal of public health = Revue canadienne de sante publique.
[50] Stirling Bryan,et al. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals. , 2007, Health economics.
[51] R. Kravitz,et al. A survey of physician attitudes and practices concerning cost-effectiveness in patient care. , 2000, The Western journal of medicine.
[52] F. Odedina,et al. Use of pharmacoeconomic data in making hospital formulary decisions. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[53] P. Marquis,et al. Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey. , 2005, Health policy.
[54] P. Johnstone,et al. Are decisions by purchasers in an English health district evidence-based? , 2002, Journal of health services research & policy.
[55] M. Drummond,et al. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology. , 1994, Social science & medicine.
[56] N. Powe,et al. Coverage Decisions for Medical Technology by Managed Care: Relationship to Organizational and Physician Payment Characteristics , 1996 .